ELAN Elanco Animal Health Incorporated
Healthcare$22.82+5.02%ClosedMarket Cap: $11.40B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.66
P/S
2.22
EV/EBITDA
19.09
DCF Value
$5.64
FCF Yield
2.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
49.4%
Operating Margin
9.0%
Net Margin
-4.9%
ROE
-3.6%
ROA
-1.8%
ROIC
3.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.37B | 57.3% | $307.0M | $57.0M | $— | — |
| Q4 null | $1.14B | 39.3% | $19.0M | $-276.0M | $— | — |
| FY null | $4.71B | 43.5% | $252.0M | $-232.0M | $— | — |
| Q3 null | $1.14B | 53.4% | $27.0M | $-34.0M | $— | — |
| Q2 null | $1.24B | 46.5% | $85.0M | $11.0M | $— | — |
| Q1 null | $1.19B | 46.6% | $121.0M | $67.0M | $— | — |
| Q4 null | $1.02B | 38.1% | $8.0M | $-8.0M | $— | — |
| FY null | $4.44B | 43.0% | $251.0M | $338.0M | $— | — |
| Q3 null | $1.03B | 39.3% | $-5.0M | $364.0M | $— | — |
| Q2 null | $1.18B | 47.1% | $115.0M | $-50.0M | $— | — |
| Q1 null | $1.21B | 46.2% | $133.0M | $32.0M | $— | — |
| Q4 2023 | $1.03B | 36.8% | $10.0M | $-141.0M | $-0.29 | — |